One of the most frequently asked questions we get at Meridien Research from patients is ‘will I get paid to participate in a research study?’ And the answer is almost always ‘Yes.’ How much someone receives, however, totally depends on the study they participate in.
Generally, if and how much participants are paid is linked to the duration and risk of the study. Trials still in the beginning phases, where the risk of serious side effects from medical treatment is much higher, often pay more.
Meridien Research’s trials are almost exclusively in phase III or IV, meaning participants are not at risk for severe side effects. Additionally, some of our trials test alternative treatments. Therefore, participants would not be required to take medications with potential side effects.
So why would a research group like Meridien pay clinical trial participants? According to authors of the journal Perspectives of Clinical Research, there are a few common reasons in addition to the ones listed earlier – including time, travel and potential trial-related injuries.
First, money could just be an appreciation for the participant’s contribution to advancing medicine. Additionally, the promise of payment could be used to enroll participants quickly in a study that needs to be completed in a short amount of time. Finally, compensation could also be a tactic to attract a target population that might otherwise be hard to reach – say certain minority groups or people with a rare condition.
In any case, participants in all Meridien Research studies are provided free medical treatment related to the condition being investigated, a form of compensation on its own. Individuals who might not otherwise be able to afford medical care can benefit from enrolling in a clinical trial, no matter if it is paid or not.
To learn more about Meridien Research’s current research studies and find out if you qualify, visit newstudyinfo.com.